
Hayfin Expects Private-Debt M&A; BI on Ozempic Risks
The Credit Edge by Bloomberg Intelligence
00:00
Potential Impact of O'Zempic on Food and Drinks Companies
Discussion on the potential impact of the weight loss drug O'Zempic on the credit and sales of food and drinks companies, including the negligible macro-level impact and the preparedness of companies for wider use of diet drugs in the future.
Transcript
Play full episode